You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 23, 2024

CLINICAL TRIALS PROFILE FOR INNOHEP


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for Innohep

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00203658 ↗ Assessment of Long-Term Out-of-Hospital Treatment of Patients With Proximal Deep Vein Thrombosis (DVT) Using Low-Molecular-Weight Heparin (LMWH) Versus LMWH Followed by Warfarin Completed Canadian Institutes of Health Research (CIHR) Phase 4 1997-04-01 The purpose of this study is to assess the long-term out-of-hospital treatment of patients with proximal venous thrombosis through the administration of subcutaneous low-molecular-weight heparin (tinzaparin sodium) versus low-molecular-weight heparin followed by warfarin sodium.
NCT00203658 ↗ Assessment of Long-Term Out-of-Hospital Treatment of Patients With Proximal Deep Vein Thrombosis (DVT) Using Low-Molecular-Weight Heparin (LMWH) Versus LMWH Followed by Warfarin Completed Dupont Applied Biosciences Phase 4 1997-04-01 The purpose of this study is to assess the long-term out-of-hospital treatment of patients with proximal venous thrombosis through the administration of subcutaneous low-molecular-weight heparin (tinzaparin sodium) versus low-molecular-weight heparin followed by warfarin sodium.
NCT00203658 ↗ Assessment of Long-Term Out-of-Hospital Treatment of Patients With Proximal Deep Vein Thrombosis (DVT) Using Low-Molecular-Weight Heparin (LMWH) Versus LMWH Followed by Warfarin Completed LEO Pharma Phase 4 1997-04-01 The purpose of this study is to assess the long-term out-of-hospital treatment of patients with proximal venous thrombosis through the administration of subcutaneous low-molecular-weight heparin (tinzaparin sodium) versus low-molecular-weight heparin followed by warfarin sodium.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Innohep

Condition Name

Condition Name for Innohep
Intervention Trials
Venous Thromboembolism 4
Deep Vein Thrombosis 3
Thromboembolism 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Innohep
Intervention Trials
Thromboembolism 8
Venous Thrombosis 7
Thrombosis 7
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Innohep

Trials by Country

Trials by Country for Innohep
Location Trials
Spain 17
Canada 10
France 5
United States 5
Sweden 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Innohep
Location Trials
New Hampshire 1
Illinois 1
New York 1
North Carolina 1
Vermont 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Innohep

Clinical Trial Phase

Clinical Trial Phase for Innohep
Clinical Trial Phase Trials
Phase 4 8
Phase 3 4
Phase 2/Phase 3 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Innohep
Clinical Trial Phase Trials
Completed 13
Not yet recruiting 4
Unknown status 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Innohep

Sponsor Name

Sponsor Name for Innohep
Sponsor Trials
LEO Pharma 11
Ottawa Hospital Research Institute 3
University of Calgary 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Innohep
Sponsor Trials
Other 30
Industry 13
NIH 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.